Stocks and Investing
Stocks and Investing
Wed, November 16, 2016
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tim Chiang Downgraded (TEVA) to Hold on, Nov 16th, 2016
Tim Chiang of BTIG, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Nov 16th, 2016.
Tim has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with Tim's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
- Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
- Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
These are the ratings of the 3 analyists that currently disagree with Tim
- Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
- Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
- Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
Contributing Sources